SCHEMBL4833409

SCHEMBL4833409

O=C(O)Cc1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccccc3Cl)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 7/20 0.41
MMP3 P08254 4/20 0.41
ALDH1A1 P00352 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38
APH1A Q96BI3 2/20 0.38
PSENEN Q9NZ42 2/20 0.38
PTGER3 P43115 1/20 0.37
ATM Q13315 1/20 0.37
FFAR1 O14842 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C1 Q04828 1/20 0.37
GNRHR P30968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833002 0.93 MAPT (0.41) MMP8MMP3ALDH1A1NPSR1KMT2A
SCHEMBL4841566 0.91 MMP8 (0.45) MMP8MMP3ALDH1A1NPSR1KMT2A
SCHEMBL4841463 0.91 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1PTGER3
SCHEMBL4840188 0.91 PPARD (0.40) MMP8MMP3ALDH1A1NPSR1KMT2A
SCHEMBL4837917 0.91 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1PTGER3
SCHEMBL4845085 0.91 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1PTGER3
SCHEMBL4842792 0.91 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1KMT2A
SCHEMBL4840055 0.90 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1FFAR1
SCHEMBL4841606 0.89 FFAR4 (0.43) MMP8MMP3ALDH1A1NPSR1
SCHEMBL4845420 0.89 FFAR4 (0.43) MMP8MMP3ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MMP8 3968/4885MMP3 3739/4885ALDH1A1 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.